Experimental drug NU-9 halts Alzheimer’s disease in animal model before symptoms begin – BioNews Central The experimental drug NU-9 significantly reduced toxic amyloid beta oligomers and related neuronal damage in a mouse model of Alzheimer's disease, demonstrating potential as an early therapeutic intervention. ...

The #ExperimentalDrug NU-9 significantly reduced toxic #AmyloidBeta oligomers and related #NeuronalDamage in a mouse model of #AlzheimersDisease, demonstrating potential as an early #TherapeuticIntervention.